Sartorius Stedim Biotech Balance Sheet Health
Financial Health criteria checks 3/6
Sartorius Stedim Biotech has a total shareholder equity of €3.9B and total debt of €3.1B, which brings its debt-to-equity ratio to 79.5%. Its total assets and total liabilities are €8.4B and €4.6B respectively. Sartorius Stedim Biotech's EBIT is €424.9M making its interest coverage ratio 3.1. It has cash and short-term investments of €727.7M.
Key information
79.5%
Debt to equity ratio
€3.07b
Debt
Interest coverage ratio | 3.1x |
Cash | €727.70m |
Equity | €3.87b |
Total liabilities | €4.57b |
Total assets | €8.44b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: SDMH.F's short term assets (€2.1B) exceed its short term liabilities (€975.4M).
Long Term Liabilities: SDMH.F's short term assets (€2.1B) do not cover its long term liabilities (€3.6B).
Debt to Equity History and Analysis
Debt Level: SDMH.F's net debt to equity ratio (60.6%) is considered high.
Reducing Debt: SDMH.F's debt to equity ratio has increased from 8.7% to 79.5% over the past 5 years.
Debt Coverage: SDMH.F's debt is well covered by operating cash flow (20.7%).
Interest Coverage: SDMH.F's interest payments on its debt are well covered by EBIT (3.1x coverage).